ABSTRACT OF THE WEEK

The Veterinary Clinics of North America. Food animal practice
Volume 37 | Issue 3 (November 2021)

Registered Medicinal Products for Use in Honey Bees in the United States and Canada.

Vet Clin North Am Food Anim Pract. November 2021;37(3):451-465.

Tracy S Farone¹

¹ Grove City College, 100 Campus Drive, Grove City, PA 16127, USA. Electronic address: tsfarone@gcc.edu.

Abstract

A 2017 US Food and Drug Administration mandate requiring veterinary oversight for medically important antibiotics used in agricultural animals, including honey bees (Apis mellifera L.) created a "new" animal requiring veterinary involvement. Many resources are available describing medical formulations of antibiotics and other drugs used in the treatment of various honey bee maladies. The goal of this article is to summarize this information in an up-to-date, practical way for the clinician. At the time of this writing, only 3 antibiotics are approved for use in honey bees and require veterinary prescriptions or veterinary feed directives.

Keywords

Antibiotic resistance; Honey bee antibiotics; Veterinary feed directive (VFD); Veterinary honey bee medications;

Article Tools:

Medline

Email to me

Archives Highlights:

Efficacy, safety and interval from end of treatment to estrus in cats treated with an ultra-low dose megestrol acetate protocol for suppression of reproductive activity.
Twenty-eight queens were treated orally with 11.5 µg/kg/day of megestrol acetate (MA) for one to six months. MA suppressed reproductive function effectively in 27/28 queens. Transient mammary and uterine hyperplasia were detected in four (14 %) and three (11 %) queens, respectively, treated for more than four months, without associated clinical signs. Significant but reversible weight gain was observed in 85 % of the animals. The resumption of cyclicity occurred on average 6 weeks after the end of treatment but was influenced by the duration of treatment and seasonality.

Nursing care of the small animal oncology patient. Part 2: pet carer support
This article outlines how RVNs can alleviate caregiver burden, facilitate shared decision-making, and provide practical and emotional support throughout the oncology journey.

Owner satisfaction and prognosis for return to work after pancarpal arthrodesis in working dogs in the United Kingdom: a retrospective study (2011-2020).
50% (5/10) owners stated their dog could perform normal duties; 4/10 (40%) could perform most duties with some allowances. 80% (8/10) owners rated the level of post-operative lameness as unaffected with a normal gait. 90% (9/10) owners were either very satisfied or satisfied with the outcome of the procedure, and 90% owners stated the financial investment was worthwhile.

Investigation of maternal mortality and stillbirth in feline dystocia after emergency obstetric care interventions: a retrospective analysis.
Medical treatment was successful in 17% of patients, and 83% underwent surgical treatment for dystocia. Ovariohysterectomy (59%) was the most common surgical method, followed by conservative caesarean section (35%).

The 4 prokinetic drugs metoclopramide, cisapride, pyridostigmine, and capromorelin do not increase fecal output or food intake in healthy New Zealand rabbits (Oryctolagus cuniculus).
Every day, rabbits produced a median of 75 g (range, 9 to 145 g) of feces, 226 fecal pellets (range, 12 to 412 pellets), and 151 mL (range, 5 to 420 mL) of urine. Metoclopramide, cisapride, pyridostigmine, and capromorelin had no effect on fecal production (both weight and number of pellets), food intake, urine production, or water intake compared to placebo at 24, 48, or 72 hours after administration.